子宫内膜异位症女性的动脉粥样硬化性心血管疾病:危险因素与早期监测前景的系统综述
本系统综述评估子宫内膜异位症与终生动脉粥样硬化性心血管疾病(ASCVD)风险的关联。两项前瞻性队列研究显示,控制人口学和生活方式混杂因素后,子宫内膜异位症女性心肌梗死(RR 1.52)、血管造影确诊的心绞痛(RR 1.91)和需冠状动脉旁路移植术(RR 1.35)的发生率更高。10项研究(407例手术确诊子宫内膜异位症患者和557例对照)显示高胆固醇血症和高血压的RR分别为1.25和1.14。目前证据提示子宫内膜异位症女性终生ASCVD风险更高,但缺乏稳健的因果证据,需未来研究确定其是否代表终生ASCVD高风险人群。
要点
- 子宫内膜异位症女性心肌梗死风险RR 1.52,心绞痛RR 1.91,冠状动脉旁路移植术RR 1.35。
- 手术确诊子宫内膜异位症患者高胆固醇血症RR 1.25,高血压RR 1.14。
- 子宫内膜异位症女性血清脂蛋白a更高、对氧磷酶1水平更低,且与疾病分期负相关(r=-0.74,P<0.0001)。
核心结论
- 目前现有证据提示,子宫内膜异位症女性终生发生ASCVD的风险高于无子宫内膜异位症的女性。
- 然而,尚缺乏稳健的因果证据,未来研究需确定子宫内膜异位症女性是否代表终生ASCVD高风险人群。
研究设计与样本
- 系统综述,检索Embase、PubMed、MEDLINE、Cochrane Register of Trials和ClinicalTrials.gov数据库。
- 纳入两项前瞻性队列研究评估终生ASCVD风险,以及10项研究(407例手术确诊子宫内膜异位症患者和557例对照)评估高胆固醇血症和高血压风险。
主要发现
- 两项前瞻性队列研究显示,控制人口学和生活方式混杂因素后,子宫内膜异位症女性心肌梗死风险RR 1.52,血管造影确诊的心绞痛风险RR 1.91,需冠状动脉旁路移植术风险RR 1.35。
- 10项研究(407例手术确诊子宫内膜异位症患者和557例对照)显示,高胆固醇血症风险RR 1.25,高血压风险RR 1.14。
- 子宫内膜异位症女性血清脂蛋白a更高、对氧磷酶1水平更低,且与疾病分期负相关(r=-0.74,P<0.0001)。
关键数值与推荐
- 心肌梗死相对风险(RR)1.52。
- 血管造影确诊的心绞痛相对风险(RR)1.91。
- 需冠状动脉旁路移植术的相对风险(RR)1.35。
- 高胆固醇血症相对风险(RR)1.25。
- 高血压相对风险(RR)1.14。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出尚缺乏稳健的因果证据。
- 原文指出未来研究需确定子宫内膜异位症女性是否代表终生ASCVD高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endometriosis and atherosclerotic cardiovascular disease (ASCVD) share similar pathogenic mechanisms. Hence, this systematic review evaluates the association between endometriosis and lifetime ASCVD risk including co-prevalence with dyslipidaemia, atherosclerosis and non-invasive markers of endothelial dysfunction. The electronic databases Embase, PubMed, MEDLINE, Cochrane Register of Trials and ClinicalTrials.gov were systematically searched for relevant articles. Two prospective cohort studies demonstrated an increased lifetime ASCVD risk after controlling for demographic and lifestyle confounders in women with endometriosis, as measured by higher incidence of myocardial infarction (relative risk [RR] 1.52), angiography-confirmed angina (RR 1.91), or requiring coronary artery bypass graft surgery (RR 1.35). Among 10 studies that included 407 patients with surgically proven endometriosis and 557 controls, RR of developing hypercholesterolemia and hypertension were 1.25 and 1.14, respectively, while higher serum lipoprotein a and lower paraoxonase 1 levels were found in women with endometriosis that was negatively correlated with stage of disease (r = -0.74, P < 0.0001). Hence, currently available evidence suggests that women with endometriosis are at higher lifetime risk of developing ASCVD than women without endometriosis. However, robust causal evidence is still lacking and future studies are needed to determine whether women with endometriosis represent a high-risk population for lifelong ASCVD risk.
引用
- Tan J, Taskin O, Iews M, et al. Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance. Reprod Biomed Online. 2019. PMID: 31735549. doi:10.1016/j.rbmo.2019.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。